VKTX
Viking Therapeutics, Inc.
Stock
$29.94−0.57 (−1.87%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$279M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$279M | — |
| 2024 | −$88M | — |
| 2023 | −$73M | — |
| 2022 | −$48M | — |
| 2021 | −$48M | — |
| 2020 | −$22M | — |
| 2019 | −$25M | — |
| 2018 | −$19M | — |
| 2017 | −$15M | — |
| 2016 | −$11M | — |
| 2015 | −$8.7M | — |
| 2014 | −$1.6M | — |